The median time to treatment initiation across all cancer types increased from 21 days in 2004 to 28 days in 2015. The median time to treatment initiation is increasing across cancer types, and this ...

These findings support the need for a phase III randomized controlled trial to definitively determine whether the addition of an antiangiogenic to a second or even a third-generation TKI provides ...

We need to rethink our approach in responding to cancers in our younger women patients,” said Hope S. Rugo, MD.

The results of our study suggest a concerning pattern in cancer center advertising, particularly among top-ranked institutions,” researchers wrote.

(HealthDay News) — China has promised to give $500 million to the World Health Organization (WHO) over the next 5 years, positioning itself to become the group’s top donor, The Washington Post ...

Our large observational study adds long-term survival to the mounting data supporting the use and safety of conservative surgery for low-risk, early-stage cervical carcinoma,” the researchers wrote.

Some pharmacists worry that tariffs could drive companies out of business while raising prices and creating more drug ...

Health care data breaches that compromised protected health information more than doubled from 2010 to 2024 in the US, data suggest.

President Donald Trump's claim that prescription drug prices will be reduced “almost immediately" under a new executive order is misleading.

The fact that this study showed a significant difference in its primary end point and the objective response rate suggests that FOLFIRINOX should be considered as a standard of care,” researchers ...

Cuts to Medicare reimbursement could prevent cancer patients from accessing care and force practices to downsize or close, radiation oncologists say.

Researchers found a significant tradeoff between harms and benefits for patients who received an ICI plus chemotherapy in the first-line setting.